Procter & Gamble Ends Manufacturing Operations In Nigeria, Reverts To Importation Of Products, Blames Hostile Business Environment

Consumer goods giant Procter & Gamble (P & G) has announced its plans to stop local manufacturing of its products in Nigeria and turn its country into an import market.  

P&G is the manufacturer of common Nigerian household items such as Pampers, Always, Oral B, Ariel, Ambi-pur, SafeGuard, Olay and Gillette.

The Chief Financial Officer of the group Andre Schulten stated this during his presentation at the Morgan Stanley Global Consumer & Retail Conference.  

The company explained that it is difficult to do business in Nigeria as a dollar-denominated organisation and the macroeconomic reality in Nigeria is responsible for its latest strategic decision.  

According to Shulten: “The other reality that arises in some of these markets is that it gets increasingly difficult to operate and create U.S dollar value. So when you think about places like Nigeria and Argentina, it is difficult for us to operate because of the macroeconomic environment.”  

“So with that in mind, we are announcing a restructuring program with the intent to adjust operating model and adjust the portfolio to ensure that we maintain the portfolio discipline that has brought us to this point.

“The restructuring program will largely focus on Nigeria and Argentina. We’ve announced that we will turn Nigeria into an import-only market, effectively dissolving our footprint on the ground in Nigeria and reverting to an import-only model”  

It further explained that the decision will help the company focus on markets that have the highest potential.  

Reacting to questions bothering on the effect of the company’s planned restructuring in Nigeria and Argentina on its overall group’s portfolio, the CFO explained that Nigeria is a $50 million net sales business.

Compared to its overall portfolio worth $85 billion, the company does not anticipate any material impact on the group’s balance sheet from a sales or profitability standpoint.  

The current macroeconomic conditions in Nigeria have negatively affected foreign USD-denominated companies in Nigeria. In August, drug maker GSK announced it’s ceasing operations in Nigeria and appointing a third party to take over distributions.  

These companies have often cited difficulty in sending back U.S. dollars outside Nigeria. The Central Bank has acknowledged it has a forex backlog to the tune of around $7 billion  

News continues after this ad

President Tinubu has instituted reforms aimed at attracting foreign investment into Nigeria, but it seems in the short term it has only brought more hardship.  

Related posts

The Nigerian Tax Reform Bills 2024: An Overview And Suggestions For Implementation

Pay Entitlements Of 54 Soldiers Jailed But Pardoned Over 2014 Rioting In Maiduguri, MURIC Appeals To COAS

Rachel Weeping For Her Children: Finding Hope For Nigeria This Christmas

This website uses Cookies to improve User experience. We assume this is OK...If not, please opt-out! Read More